Cargando…
Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer
BACKGROUND: The c‐MET protein, encoded by the mesenchymal‐epithelial transition factor (MET) gene, can regulate cell proliferation, migration and invasion. Studies have shown that it is one of the essential driver genes for non‐small cell lung cancer (NSCLC). Currently, several clinical studies have...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151136/ https://www.ncbi.nlm.nih.gov/pubmed/36944506 http://dx.doi.org/10.1111/1759-7714.14848 |